Aberrant signal transduction pathways in myeloproliferative neoplasms
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Link
http://www.nature.com/articles/leu2008236.pdf
Reference154 articles.
1. Tefferi A, Gangat N, Wolanskyj AP, Schwager S, Pardanani A, Lasho TL et al. 20+ Year without leukemic or fibrotic transformation in essential thrombocythemia or polycythemia vera: predictors at diagnosis. Eur J Haematol 2008; 80: 386–390.
2. Damashek W . Some speculations on the myeloproliferative syndromes. Blood 1951; 6: 372–375.
3. Adamson JW . Analysis of haemopoiesis: the use of cell markers and in vitro culture techniques in studies of clonal haemopathies in man. Clin Haematol 1984; 13: 489–502.
4. Prchal JF, Axelrad AA . Bone-marrow responses in polycythemia vera. N Engl J Med 1974; 290: 1382.
5. Roder S, Steimle C, Meinhardt G, Pahl HL . STAT3 is constitutively active in some patients with polycythemia rubra vera. Exp Hematol 2001; 29: 694–702.
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. 2022 Cannon lecture: an ode to signal transduction: how the growth hormone pathway revealed insight into height, malignancy, and obesity;American Journal of Physiology-Endocrinology and Metabolism;2023-11-01
2. Formononetin acts synergistically with a JAK2 inhibitor to suppress growth in myeloproliferative neoplasm by inhibiting JAK/STAT3 signaling pathway;Tropical Journal of Pharmaceutical Research;2023-07-12
3. von Willebrand factor activity levels are influenced by driver mutation status in polycythemia vera and essential thrombocythemia patients with well‐controlled platelet counts;European Journal of Haematology;2022-09-28
4. Developmental changes in iron metabolism and erythropoiesis in mice with human gain‐of‐function erythropoietin receptor;American Journal of Hematology;2022-07-23
5. Addressing symptom burden in myeloproliferative neoplasms;Best Practice & Research Clinical Haematology;2022-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3